The cancer drug Vecade (bortezomib) combined with glucocorticoids could be a treatment option for people with drug-resistant lupus nephritis (LN), suggests a study published in the scientific journal Lupus.
Articles by Özge Özkaya, PhD
Patients with one autoimmune disease should be closely monitored because they may have a higher risk of developing another autoimmune disease according to a study published in the journal Autoimmune Highlights.
The flu vaccine is effective and associated with a lower risk of hospitalization, pneumonia, admission to the intensive care unit, in-hospital dialysis, and death in people with systemic lupus erythematosus (SLE), a study published in the leading scientific journal Scientific Reports suggests.
The presence of anti-ficolin 3 antibodies could be used as a biomarker to diagnose active lupus with kidney involvement according to a study published in the scientific journal Plos One.
Maintaining optimal levels of vitamin D in the blood could be protective against the risk of cardiovascular disease often seen in systemic lupus erythematosus (SLE) patients, according to a large literature review conducted on the subject.
Autoantibodies that naturally occur in the body of a population of patients with an ultra-rare type of autoimmune disorder called autoimmune polyendocrine syndrome type 1 (APS1 or APECED), could help fight a variety of human diseases including lupus.
Ten marker genes related to systemic lupus erythematosus (SLE) were identified from three different types of blood samples. These genes may have the potential to be used as biomarkers to diagnose or even predict SLE. They could also be used as therapeutic markers to measure how well SLE patients respond to treatment.